3-3-15 Kamiminami, Hirano-ku, Osaka-shi, Osaka prefecture 547-0003, Japan
Manager
Yuji Takahashi (Ph.D.)
Capital
10 million JPY
Projects
1. Sales and R&D of supplements for pregnancy 2. R&D of novel products for reproductive medicine 3. Medical support 4. Others
History
2015/1
TK Health Research LCC. was established
2016/7
Business of supplement started
2016/9
A trademark ‘Astamama’ was obtained
2017/2
Capital increase
2017/4
TK Health Research Co., Ltd. was established (reorganized)
2017/6
A patent on ophthalmic composition was applied with the University of Tokyo
2022/5
A US patent on ophthalmic composition was obtained
2024/3
A trademark ‘Ovacare’ was obtained
2024/7
Chinese trademarks ‘Astamama’, ‘Astapapa’, Ovacare’, and ‘Men’s Repro’ were obtained
2024/8
An R&D center was opened (Keihanna Plaza Laboratory wing, Kyoto)
2024年10月
A trademark ‘Men’s Repro’ was obtained
Our research career
Yuji Takahashi (CEO)
1996~2000 University of Virginia, USA / 2000~2002 the University of Tokyo / 2002~2012 National Center for Child Health and Development: Research Associate in reproductive biology and reproductive medicine
2012~2016 Shanghai ReMed, R&M, Rebright biotech: R&D Planning Director, and vice president
2015~ TK Health Research
Junwen Qin
(R&D Planning director)
1992~2000 Hebei Agricultural University: Lecturer
2009 – 2014 Jinan University: Professor
2015 – 2017 Research Advisor at TK Health Research
2017 – Current position at TK Health Research
Contact us
by mail
From the top blank to the bottom, please enter ‘Company name’, ‘Your name (required)’, ‘Your mail address (required)’, ‘your phone number’ and ‘Your inquiry (required)’, and then click the blue box on the left bottom.